Oculogica

New York, United States Founded: 2013 • Age: 13 yrs
Eye-tracking technology is utilized to detect traumatic brain injuries.
Request Access

About Oculogica

Oculogica is a company based in New York (United States) founded in 2013.. Oculogica has raised $21.98 million across 7 funding rounds from investors including HHS and TitletownTech. Oculogica offers products and services including EyeBOX. Oculogica operates in a competitive market with competitors including Tobii Dynavox, NovaSight, Artiria, C. Light Technologies and RetiSpec, among others.

  • Headquarter New York, United States
  • Sectors
    Healthcare
    Technology
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Health Technology & Digital Health
Technology → Artificial Intelligence & Machine Learning
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $21.98 M (USD)

    in 7 rounds

  • Latest Funding Round
    $7.57 M (USD), Series B

    Apr 26, 2024

  • Investors
    HHS

    & 1 more

  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Oculogica

Oculogica offers a comprehensive portfolio of products and services, including EyeBOX. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Measures eye movements for rapid, non-invasive concussion detection.

People of Oculogica
Headcount 1-10
Employee Profiles 7
Board Members and Advisors 4
Employee Profiles
People
Joel Sanderson
Chief Technology Officer
People
Rosina Samadani
CEO
People
Dan Sanderson
Principal Engineer
People
Darryl Mayeaux (he/him)
Data Scientist

Unlock access to complete

Board Members and Advisors
people
Uzma Samadani
Founder & Scientific Advisor

Unlock access to complete

Funding Insights of Oculogica

Oculogica has successfully raised a total of $21.98M across 7 strategic funding rounds. The most recent funding activity was a Series B round of $7.57 million completed in April 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 7
  • Last Round Series B — $7.6M
  • First Round

    (16 Jul 2014)

  • Investors Count 2
Date Amount Transaction Name Valuation Lead Investors Investors
Apr, 2024 Amount Series B - Oculogica Valuation

investors

Mar, 2022 Amount Series A - Oculogica Valuation

investors

Mar, 2022 Amount Debt – Conventional - Oculogica Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Oculogica

Oculogica has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS and TitletownTech. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
-
Founded Year Domain Location
Public health and human services are overseen by HHS.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Oculogica

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Oculogica

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Oculogica Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Oculogica

Oculogica operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Tobii Dynavox, NovaSight, Artiria, C. Light Technologies and RetiSpec, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Assistive communication solutions via eye-tracking are provided for differently-abled individuals.
domain founded_year HQ Location
Eye-tracking solutions for vision assessment and treatment are provided.
domain founded_year HQ Location
Micro-navigation systems for stroke surgery are developed.
domain founded_year HQ Location
Eye-tracking devices are developed for neurodegenerative disease monitoring.
domain founded_year HQ Location
Non-invasive eye scanner for early Alzheimer’s detection is developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Oculogica

Frequently Asked Questions about Oculogica

When was Oculogica founded?

Oculogica was founded in 2013 and raised its 1st funding round 1 year after it was founded.

Where is Oculogica located?

Oculogica is headquartered in New York, United States. It is registered at New York, New York, United States.

Is Oculogica a funded company?

Oculogica is a funded company, having raised a total of $21.98M across 7 funding rounds to date. The company's 1st funding round was a Series A of $4.05M, raised on Jul 16, 2014.

What does Oculogica do?

Oculogica was founded in 2013 and is based in New York, United States. Operations focus on the medical technology sector, where eye-tracking solutions are developed to assess brain function. The EyeBox CNS device, authorized by the FDA, aids in concussion diagnosis by identifying cranial nerve weaknesses without requiring baseline data or calibration. Four patents are held, along with three working papers, supporting pathology location and nature analysis.

Who are the top competitors of Oculogica?

Oculogica's top competitors include NovaSight, RetiSpec and Tobii Dynavox.

What products or services does Oculogica offer?

Oculogica offers EyeBOX.

Who are Oculogica's investors?

Oculogica has 2 investors. Key investors include HHS, and TitletownTech.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available